Association for Cancer Physicians releases cancer patient strategy for UK

January 05, 2016

The Association for Cancer Physicians (ACP), which represents and supports medical oncologists in the UK, has published a new Strategy for improving cancer patient services and outcomes.

The Strategy has been published in the open-access journal ecancermedicalscience, where it is freely available to read.

"The ACP, with input from patients, has worked hard to produce this Strategy," says strategy author Prof Peter Selby, Professor of Cancer Medicine at the University of Leeds and Consultant Physician at St James's University Hospital.

"The Strategy focuses on improving the quality of life and survival of cancer patients towards the goal in two decades of over 70% of patients surviving for more than 10 years."

"Cancer is a common problem, directly affecting 1 in 2 people in their lifetime," notes author Dr Sarah Payne, an Honorary Consultant at Guy's and St Thomas' NHS Trust, and Medical Affairs Manager of Pfizer UK.

She explains that advances in prevention and early detection, treatment options for patients, and understanding of the biology of the disease have led to over 50% of UK cancer patients surviving their disease for 10 years or more.

"Oncology as a specialty has contributed substantially to these improvements over the last 25 years," says Dr Payne.

The comprehensive Strategy is authored by influential medical oncologists from around the UK, who invited input from experts in each area, as well as patient perspectives. It reflects a significant evolution of medical oncology planning and practice in the United Kingdom.

In the UK, as in the rest of Europe, healthcare is under tremendous pressure, the strategy explains, with increasing service demands, an aging population and increasing costs generating pressure on NHS services.

The authors feel that medical oncology is in a place to provide leadership and support for colleagues in all of the healthcare professions in the management of the pressures in cancer care.

"Notably, the aims are to improve the delivery of excellent and safe medical oncology care for patients, contribute to the overall development of the NHS and provide a substantial contribution to the development of innovative approaches to cancer care," continues Dr Sarah Payne. "This is vital at a time of unprecedented acceleration of knowledge, rapid changes in the management of patients and the therapies available and the increased demand on cancer services and financial constraints on the NHS.

The aim is for the strategy to bring about the developments and changes through the actions of its members at all stages of their career and their involvement with policy makers at the local, national and international levels."

The strategy is "a living document" and will be reviewed annually, reflecting the changing landscape of cancer care in the UK.

The authors write, "We hope to be able to show steady progress in the outcomes for our patients and demonstrate the value of the ACP's increasing contributions, as the specialty of Medical Oncology continues to grow in coming years."
Read the Strategy Document in full here:

Watch an interview with Prof Peter Selby here:


Baird Richard, Banks Ian, Cameron David, Chester John, Earl Helena, Flannagan Mark, Januszewski Adam, Kennedy Richard, Payne Sarah, Samuel Emlyn, Taylor Hannah, Agarwal Roshan, Ahmed Samreen, Archer Caroline, Board Ruth, Carser Judith, Copson Ellen, Cunningham David, Coleman Rob, Dangoor Adam, Dark Graham, Eccles Diana, Gallagher Chris, Glaser Adam, Griffiths Richard, Hall Geoff, Hall Marcia, Harari Danielle, Hawkins Michael, Hill Mark, Johnson Peter, Jones Alison, Kalsi Tania, Karapanagiotou Eleni, Kemp Zoe, Mansi Janine, Marshall Ernie, Mitchell Alex, Moe Maung, Michie Caroline, Neal Richard, Newsom-Davis Tom, Norton Alison, Osborne Richard, Patel Gargi, Radford John, Ring Alistair, Shaw Emily, Skinner Rod, Stark Dan, Turnbull Sam, Velikova Galina, White Jeff, Young Alison, Joffe Johnathan and Selby Peter (2016) An Association of Cancer Physicians' strategy for improving services and outcomes for cancer patients ecancer 10 608


Related Cancer Articles from Brightsurf:

New blood cancer treatment works by selectively interfering with cancer cell signalling
University of Alberta scientists have identified the mechanism of action behind a new type of precision cancer drug for blood cancers that is set for human trials, according to research published in Nature Communications.

UCI researchers uncover cancer cell vulnerabilities; may lead to better cancer therapies
A new University of California, Irvine-led study reveals a protein responsible for genetic changes resulting in a variety of cancers, may also be the key to more effective, targeted cancer therapy.

Breast cancer treatment costs highest among young women with metastic cancer
In a fight for their lives, young women, age 18-44, spend double the amount of older women to survive metastatic breast cancer, according to a large statewide study by the University of North Carolina at Chapel Hill.

Cancer mortality continues steady decline, driven by progress against lung cancer
The cancer death rate declined by 29% from 1991 to 2017, including a 2.2% drop from 2016 to 2017, the largest single-year drop in cancer mortality ever reported.

Stress in cervical cancer patients associated with higher risk of cancer-specific mortality
Psychological stress was associated with a higher risk of cancer-specific mortality in women diagnosed with cervical cancer.

Cancer-sniffing dogs 97% accurate in identifying lung cancer, according to study in JAOA
The next step will be to further fractionate the samples based on chemical and physical properties, presenting them back to the dogs until the specific biomarkers for each cancer are identified.

Moffitt Cancer Center researchers identify one way T cell function may fail in cancer
Moffitt Cancer Center researchers have discovered a mechanism by which one type of immune cell, CD8+ T cells, can become dysfunctional, impeding its ability to seek and kill cancer cells.

More cancer survivors, fewer cancer specialists point to challenge in meeting care needs
An aging population, a growing number of cancer survivors, and a projected shortage of cancer care providers will result in a challenge in delivering the care for cancer survivors in the United States if systemic changes are not made.

New cancer vaccine platform a potential tool for efficacious targeted cancer therapy
Researchers at the University of Helsinki have discovered a solution in the form of a cancer vaccine platform for improving the efficacy of oncolytic viruses used in cancer treatment.

American Cancer Society outlines blueprint for cancer control in the 21st century
The American Cancer Society is outlining its vision for cancer control in the decades ahead in a series of articles that forms the basis of a national cancer control plan.

Read More: Cancer News and Cancer Current Events is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to